Related Experiment Video
Updated: Jul 12, 2026

In Vitro Transcription Assays and Their Application in Drug Discovery
Published on: September 20, 2016
Novel anti-infection agents: small-molecule inhibitors of bacterial transcription factors
Todd E Bowser1, Victoria J Bartlett, Mark C Grier
1Paratek Pharmaceuticals, Inc., 75 Kneeland Street, Boston, MA 02111, USA. tbowser@paratekpharm.com
Abstract:
Structure-based drug design was utilized to identify potent small-molecule inhibitors of proteins within the AraC family of bacterial transcription factors, which control virulence in medically important microbes. These agents represent a novel approach to fight infectious disease and may be less likely to promote resistance development. These compounds lack intrinsic antibacterial activity in vitro and were able to limit a bacterial infection in a mouse model of urinary tract infection.
Related Concept Videos
Inhibitors of Bacterial Protein Synthesis
Eukaryotic Transcription Inhibitors
Eukaryotic transcription inhibitors usually contain two distinct domains, a DNA...
Bacterial RNA Polymerase
In most genes, the transcription site is a single base present upstream of the coding sequence. Though RNAP is a catalytically efficient enzyme, it does not recognize...
Inhibitors of Bacterial DNA Synthesis
Types of RNA
Three main types of RNA are involved in protein synthesis: messenger RNA (mRNA), transfer RNA (tRNA), and ribosomal RNA (rRNA). These RNAs perform diverse functions and can be broadly classified as protein-coding or non-coding RNA. Non-coding RNAs play important roles in the regulation of gene expression in response to developmental and environmental changes. Non-coding RNAs in prokaryotes can be manipulated to develop more effective antibacterial drugs for human or animal use.
RNA...
Inhibitors of Viral Protein Synthesis

